Kong Rong Pan
Chief Operating Officer at PEIJIA MEDICAL LIMITED
Profile
Kong Rong Pan is currently the Chief Operating Officer at Peijia Medical Technology (Suzhou) Co., Ltd.
and Peijia Medical Ltd.
He previously worked as the Senior Vice President-Manufacturing & Operation at MicroPort Scientific Corp.
and as the Senior Vice President-Supply Chain at Shanghai Microport Medical (Group) Co., Ltd.
Mr. Pan received his undergraduate degree from Beihang University, his graduate degree from Shanghai University of Technology, and two graduate degrees from The Curtis L.
Carlson School of Management.
Kong Rong Pan active positions
Companies | Position | Start |
---|---|---|
PEIJIA MEDICAL LIMITED | Chief Operating Officer | - |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Chief Operating Officer | 2017-07-31 |
Former positions of Kong Rong Pan
Companies | Position | End |
---|---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Corporate Officer/Principal | 2015-11-30 |
MICROPORT SCIENTIFIC CORPORATION | Chief Operating Officer | - |
Training of Kong Rong Pan
Beihang University | Undergraduate Degree |
Shanghai University of Technology | Graduate Degree |
The Curtis L. Carlson School of Management | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
PEIJIA MEDICAL LIMITED | Health Technology |
Private companies | 2 |
---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Technology |
Peijia Medical Technology (Suzhou) Co. Ltd.
Peijia Medical Technology (Suzhou) Co. Ltd. Medical SpecialtiesHealth Technology Peijia Medical Technology (Suzhou) Co. Ltd. is a global medical innovation solution provider founded in 2013. The private company is based in Suzhou, China. The Chinese company specializes in treating intracranial aneurysms, which are abnormal bulges that occur in blood vessels in the brain due to congenital abnormalities or damage caused by various factors. The company offers intracranial aneurysm embolization intervention treatment, which involves blocking blood flow into the aneurysm without blocking surrounding small arteries or narrowing the main blood vessels. The treatment is performed using devices such as embolization spring coils, intracranial aneurysm stents, and vascular reconstruction devices. | Health Technology |
- Stock Market
- Insiders
- Kong Rong Pan